A glioblastoma study employing a combinatorial treatment to target both VEGF and CD47, the latter of which inhibited the phagocytic effect of macrophages, revealed that it could trigger autophagy of cancer cells which attenuated the phagocytosis and cytotoxicity of macrophage population. Here, CD47 is linked to glioblastoma.